关注我们
NNZ-2566
添加购物车| 名称 | NNZ-2566 |
|---|---|
| CAS No. | 853400-76-7 |
| 目录号 | ONP20203 |
| 规格 | mg/g/kg |
| 纯度 | ≥98% |
| 价格 | 更多在线询价 |
| 贮存 | -20°C |
| 分子量 | 315.326 |
| 序列结构 | H-Gly-aMePro-Glu-OH |
| 库存 | |
| 产品简述 | Trofinetide (NNZ-2566) is a drug developed by Neuren Pharmaceuticals that acts as an analogue of the neuropeptide (1-3) IGF-1, which is a simple tripeptide with sequence Gly-Pro-Glu formed by enzymatic cleavage of the growth factor IGF-1 within the brain. Trofinetide has anti-inflammatory properties and was originally developed as a potential treatment for stroke, but has subsequently been developed for other applications and is now in Phase II clinical trials against Fragile X syndrome and Rett syndrome. |